News About: Pharm. Industry
KPMA to name Mr. Moon Kyung-tae as executive director.The Korea Pharmaceutical Manufacturers Association (KPMA) internally appointed Mr. Moon Kyung-tae, ex-MOHW policy information administration officer, as the executive director, ...
|
Choa to set up Bio-engineering Institute and investment.
Prof. Kim Jin-hoe of Kyungsang Univ. and Choa Pharm. Co. agreed to invest about 4 billion won for the 7 year R&D projects on the cloned pigs transformed with EPO genes.
Choa said that the EPO study by the use of tr...
AZ Korea to hire Mr. Madan as CFO.AstraZeneca Korea announced that Mr. Rohini Krishnan Madan from AZ Turkey was invited to the post of CFO as of Feb. 1, 2006.
He joined AZ Turkey in 1998, promoted to the vice...
|
Kyungdong to register U.S. patent for famciclovir production.
Kyungdong Pharmaceutical company announced that a patent for the production process of famciclovir was completed to register in the United States, under the title of "Manufacturing method of 9-［4-acetyoxy-3-(acetoxyme...
Lyplinol enjoying after NSAIDs side effect report.
A functional health food product for arthritis named Lyplinol has emerged with a rising popularity in the market after the recent KFDA's announcement of the NSAID side effects.
Lyplinol was encapsulated with active...
New policy of Zuellig for returned stocks.
Zuellig's policy of the returned goods seems to be modified, probably stemming from the frictions between drug wholesalers and KPA, a pharmacist group.
According to Annex 3 of Zuellig's new distribution agreement (...
Samjin to file patent of new therapeutic compound for C hepatitis.
Samjin has filed the patent registration to the Patent Office for a new pyrimidinedione derivative developed by Central Research Institute as an anti-viral agent, having an anti-viral activity against C hepatitis viru...
LG Life Science to apply human growth hormone for FDA approval.
LG Life Science announced on Feb. 15 that the company applied the U. S. FDA approval for Valtropin, a human growth hormone developed by the LG bio technology.
The company said "The FDA registration dossier submitt...
Janssen Korea to launch one-a-day drug for incontinence of urine.
Janssen Korea has launched Lyrinel (oxybutynine), a one-a-day dosed therapy for the incontinence of urine, by using the OROS technology, a sustained releasing drug delivery system.
The indication included the incon...
Hyundai reporting growth of sales and net profits.
Hyundai reported the 2005 business performances in the 42nd general shareholder's meeting on Feb. 13 at 101,100 million won of sales, 8,800 million won of operating incomes, 6,200 million won of net profits and 700 wo...
